Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
September 16, 2022 8:17 AM 3 min read

High Tide's Second Quarter And Outlook: M&As And Organic Openings Coming Soon?

by Nicolás Jose Rodriguez Benzinga Staff Writer
Follow

The Analyst

Pablo Zuanic from Cantor Fitzgerald maintained a Neutral rating on High Tide Inc., lowering its 12-month price target to C$2.75 from C$2.80, "given the overall sectoral derating and industry challenges."

"High Tide continues to consolidate the Canadian retail industry (Choom being the latest deal), is expanding its discount loyalty program, and is achieving double-digit same-store sales growth north of 20%. That said, given tough retail cannabis industry dynamics and a lack of visibility on medium-term profit margins and cash flow, we prefer to remain sidelined," Zuanic explained. 

HITI’s Second Quarter: Retail Sales And 'Cash Burn' Increase

HITI's total sales in the July quarter were up 18% sequentially to $95.4 million, compared with CA $81 (US$61.1 million) in the prior quarter. On an annual basis, sales increased by 98% compared with sales in the third quarter of 2021 ($48.1 million).

The Canadian retail business grew 31% sequentially to $75 million (inc. M&A), compared with 23% sequential growth in the prior quarter and sales of $57 million.

“The company finished the quarter with 131 stores, and the loyalty program now has over 750,000 members, of which the company confirmed accounts for over 90% of daily transactions. Canadian retail sales growth was driven by same-store sales gains (+18% QoQ, +46% YoY) and the addition of six new stores,” Zuanic said. “The US business (mostly CBD and accessories) fell 20% sequentially to $12.8 million, partly due to consumer spend pressures.”

Zuanic also noted that the international piece (mostly Blessed CBD in the UK) increased to $1.9 million from $1.6 million. “Reported gross margins were 27% vs. 28% in the April quarter (Canada 23%; US 47%); management attributes the small sequential margin compression to a high percentage of the sales mix coming from Canadian retail sales (78% in 2Q22 compared to 85% in 3Q22), which have lower margins.”

Adjusted EBITDA increased 77% sequentially to $4.2Mn (op cash flow was C$0Mn) from C$2.4Mn, and negative free cash flow improved to -C$2.1Mn from $4.7Mn in April. “Still, net debt appears to be manageable at 0.1x sales,” Zuanic added.

According to Zuanic, management is pleased with HITI's performance. “The company says that it continues to gain Canadian cannabis retail market share and that it has generated sequential same-store sales growth north of 18% for three quarters in a row.”

“For the July quarter, we calculate High Tide had a 7.6% retail share, excluding Quebec, vs. 6.2% in the April quarter,” Zuanic said. Retail gross profits, increased sequentially by CA $5 million to CA $18.9 million. However, Zuanic said negative EBIT for the Canadian piece “remains north of -$4 million.”

“With gross margins stabilizing (...), [it] is key for the Canadian unit to become EBIT positive and to reduce cash burn,” the analyst said.

Outlook: Organic Openings And Accretive M&A

Zuanic explained that management confirmed prior plans to reach 150 stores by the end of 2022, “via M&A and organic openings,” and it is currently on “an annual run-rate exceeding C$400Mn in revenues.”

After the end of the July quarter, the company closed on the Choom acquisition of a nine-store portfolio. The nine stores generated, on an annual basis, CA $10.2 million in sales and CA $1.3 million in EBITDA.

HITI confirmed its plans to expand its retail presence in British Columbia via “organic openings and accretive M&A.” The company anticipates launching a paid version of the Cabana Club program. It expects the private label program “to account for 20-30% of cannabis retail sales.”

In the US and Europe, HITI continues to expand its CBD offerings, recently entering Germany after the UK acquisition of Blessed CBD (with hemp-derived CBD).

Photo by Lance Asper on Unsplash. 

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorCannabisEarningsLarge CapM&ANewsGuidanceRetail SalesManagementEconomicsMarketsAnalyst Ratingsanalyst ratingOutlookPablo Zuanic
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter

“Management stated that it plans to be active in attempting to participate in German recreational sales, which the company anticipates will not start before 2024. Management anticipates that tough macro conditions will force approximately one-third of Canadian retail stores to close, helping to drive its market-share gains and increase M&A opportunities,” Zuanic concluded.

Comments
Loading...